Milestone Pharmaceuticals (MIST) Competitor Comparison
We are evaluating the key criteria listed to compare Milestone Pharmaceuticals (MIST) against its competitors in the Biotechnology industry.
Market Capitalization
278 / 368Gross Profits
110 / 278Total Revenue
203 / 300EBITDA
151 / 337Free Cashflow
171 / 352Quick Ratio
83 / 357Earnings per Share
135 / 359Dividend yield
0 / 6Total Cash
236 / 358Performance 3 years
193 / 368Performance 5 years
278 / 368Performance 10 years
236 / 368Linearity 3 years
121 / 368Linearity 5 years
253 / 368Linearity 10 years
213 / 368Total Rank
199 / 368Dividend Rank
205 / 368Valuation Rank
218 / 368Piotroski Rank
357 / 368Muliplier Rank
86 / 368Earnings per Share - MIST ranking 135 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.